Glycomet Trio Forte 1 Tablets

Glycomet Trio Forte 1 is a triple-action anti-diabetic formulation that combines Voglibose (0.2 mg), Glimepiride (1 mg), and Metformin Hydrochloride (1000 mg, sustained release).

It helps manage Type 2 Diabetes Mellitus effectively by improving insulin function, reducing glucose absorption, and balancing blood sugar levels throughout the day.

Manufacturer: USV Private Limited

• Triple-action therapy for effective diabetes control.
• Delays carbohydrate absorption from the intestine (Voglibose).
• Enhances insulin secretion (Glimepiride).
• Improves insulin sensitivity and reduces hepatic glucose production (Metformin).
• Maintains blood glucose stability throughout the day.

• Voglibose IP: 0.2 mg
• Glimepiride IP: 1 mg
• Metformin Hydrochloride IP (Sustained Release): 1000 mg
• Colour: Yellow Oxide of Iron
• Excipients: q.s.

As per pack: “Each uncoated bilayered tablet contains Voglibose 0.2 mg, Glimepiride 1 mg, and Metformin Hydrochloride 1000 mg (sustained release form).”

• Take as prescribed by your physician.
• Swallow whole with water; do not crush or chew.
• Best taken before or with meals for optimal control of postprandial glucose spikes.

Important: Do not crush or chew the tablet. Take with water as per doctor’s instructions.

• Storage: Store in a dry place at a temperature below 30°C. Protect from light.
• Keep out of reach of children.
• Discard unused medicine after expiry date.

• Schedule G & H Prescription Drug: Not to be sold without the prescription of a Registered Medical Practitioner.
• Consult your doctor before use if you have liver, kidney, or heart issues.
• Monitor blood sugar regularly during treatment.
• Avoid alcohol; follow a healthy diet and exercise plan.

Disclaimer: For informational use only. Always use under medical supervision. Product details may vary with manufacturer updates.